Ilumetri is a medicine that acts on the immune system and is used to treat plaque psoriasis, a disease causing red, scaly patches on the skin. It is used in adults with moderate to severe disease for whom treatments applied to the skin are not suitable. Ilumetri contains the active substance tildrakizumab.
Therapeutic Indication
### Therapeutic indication Ilumetri is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
Therapeutic Area (MeSH)
ATC Code
L04AC
ATC Item
白细胞介素抑制剂
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| tildrakizumab | N/A | 替瑞奇珠单抗 |
EMA Name
Ilumetri
Medicine Name
Ilumetri
Aliases
N/ANo risk management plan link.
